- $45.08bn
- $39.02bn
- $2.75bn
- 100
- 16
- 91
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 34.67 | ||
| PEG Ratio (f) | 1.29 | ||
| EPS Growth (f) | 36.81% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.26 | ||
| Price to Tang. Book | 7.87 | ||
| Price to Free Cashflow | 38.02 | ||
| Price to Sales | 15.79 | ||
| EV to EBITDA | 48.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.21% | ||
| Return on Equity | 14.07% | ||
| Operating Margin | 26.97% | ||
Financial Summary
| Year End 31st Jan | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,465.07 | 1,850.78 | 2,155.06 | 2,363.67 | 2,746.62 | 3,098.89 | 3,450.89 | 19.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +67.85 | -5.41 | +12.76 | +28.7 | -0.84 | +76.3 | +8.75 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
Directors
- Gordon Ritter NEC (56)
- Thomas Schwenger PRE (53)
- Peter Gassner CEO (56)
- Brent Bowman CFO (54)
- Alan Mateo EVP (59)
- Jonathan Faddis SVP (49)
- Frederic Lequient SVP (52)
- E. Nitsa Zuppas CMO (51)
- Timothy Cabral DRC (53)
- Priscilla Hung DRC (54)
- Tina Hunt DRC (53)
- Marshall Mohr DRC (65)
- Matthew Wallach DRC (48)
- Ronald Codd IND (65)
- Last Annual
- January 31st, 2025
- Last Interim
- April 30th, 2025
- Incorporated
- January 12th, 2007
- Public Since
- October 16th, 2013
- No. of Shareholders
- 17
- No. of Employees
- 7,291
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 163,412,273
- Address
- 4280 Hacienda Drive, PLEASANTON, 94588
- Web
- https://www.veeva.com/medtech/
- Phone
- +1 9254526500
- Contact
- Gunnar Hansen
- Auditors
- KPMG LLP
Latest News for VEEV
Upcoming Events for VEEV
Q2 2026 Veeva Systems Inc Earnings Release
Q3 2026 Veeva Systems Inc Earnings Release
Similar to VEEV
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
As of Today at 23:57 UTC, shares in Veeva Systems are trading at $275.89. This share price information is delayed by 15 minutes.
Shares in Veeva Systems last closed at $275.89 and the price had moved by +48.34% over the past 365 days. In terms of relative price strength the Veeva Systems share price has outperformed the S&P500 Index by +33.07% over the past year.
The overall consensus recommendation for Veeva Systems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreVeeva Systems does not currently pay a dividend.
Veeva Systems does not currently pay a dividend.
Veeva Systems does not currently pay a dividend.
To buy shares in Veeva Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $275.89, shares in Veeva Systems had a market capitalisation of $45.08bn.
Here are the trading details for Veeva Systems:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: VEEV
Based on an overall assessment of its quality, value and momentum Veeva Systems is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Veeva Systems is $292.62. That is 6.06% above the last closing price of $275.89.
Analysts covering Veeva Systems currently have a consensus Earnings Per Share (EPS) forecast of $7.66 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Veeva Systems. Over the past six months, its share price has outperformed the S&P500 Index by +18.13%.
As of the last closing price of $275.89, shares in Veeva Systems were trading +18.23% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Veeva Systems PE ratio based on its reported earnings over the past 12 months is 34.67. The shares last closed at $275.89.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Veeva Systems' management team is headed by:
- Gordon Ritter - NEC
- Thomas Schwenger - PRE
- Peter Gassner - CEO
- Brent Bowman - CFO
- Alan Mateo - EVP
- Jonathan Faddis - SVP
- Frederic Lequient - SVP
- E. Nitsa Zuppas - CMO
- Timothy Cabral - DRC
- Priscilla Hung - DRC
- Tina Hunt - DRC
- Marshall Mohr - DRC
- Matthew Wallach - DRC
- Ronald Codd - IND